ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.87
-0.06%
US Tech 100
18,183.52
-0.07%
S&P 500
5,311.41
0.06%
US Dollar vs CAD
1.36496
0.19%
Bitcoin
70,075.50
-1.92%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Invitae Corporation (NVTA)

  7. Invitae Corporation (NVTA) News

NVTA

Invitae (NVTA)

Invitae Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:NVTA
DateTimeSourceHeadlineSymbolCompany
03/06/20247:31AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
02/06/20244:07PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
01/30/20246:00AMPR Newswire (US)Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease TherapeuticsNYSE:NVTAInvitae Corporation
01/29/20243:01PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:NVTAInvitae Corporation
01/24/20243:34PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:NVTAInvitae Corporation
01/22/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
01/22/20246:00AMPR Newswire (US)Invitae Completes Sale of Reproductive Health Assets to NateraNYSE:NVTAInvitae Corporation
01/18/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
12/21/20238:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
12/21/20238:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
12/14/20233:29PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
12/13/20233:07PMPR Newswire (US)Invitae Divests Ciitizen Health Data Platform and Implements Further Cost CutsNYSE:NVTAInvitae Corporation
12/11/20233:41PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
11/17/20233:48PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
11/15/20233:22PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
11/14/20236:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
11/14/20236:55PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
11/08/20233:36PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NVTAInvitae Corporation
11/08/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
11/08/20233:01PMPR Newswire (US)Invitae Reports Third Quarter 2023 Financial ResultsNYSE:NVTAInvitae Corporation
11/06/20233:00PMPR Newswire (US)Invitae Launches Enhanced Chemistry of MRD Test to Better Serve Biopharmaceutical Clinical and Research PartnershipsNYSE:NVTAInvitae Corporation
11/01/20235:59AMPR Newswire (US)Invitae to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023NYSE:NVTAInvitae Corporation
10/25/202310:00AMPR Newswire (US)Landmark Study Reveals Magnitude of Uncertain Results in Clinical Genetic Testing for Hereditary Disease, Points to Evidence-Based Solutions to Reach Definitive ResultsNYSE:NVTAInvitae Corporation
10/20/20235:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
10/19/20233:38PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
10/19/20233:30PMPR Newswire (US)Invitae Appoints Dr. David Sholehvar as Chief Operating OfficerNYSE:NVTAInvitae Corporation
10/12/20233:15PMPR Newswire (US)Rural Hospital System Demonstrates the Clinical Benefits of Implementing Universal Hereditary Cancer Testing in Patients with Breast CancerNYSE:NVTAInvitae Corporation
10/10/20233:30PMPR Newswire (US)Invitae to Present Data at the National Society of Genetic Counselors 42nd Annual Conference That Supports Advancements in Medical GenomicsNYSE:NVTAInvitae Corporation
10/03/202311:07AMPR Newswire (US)Invitae's Common Hereditary Cancers Panel Receives FDA Market AuthorizationNYSE:NVTAInvitae Corporation
10/02/20238:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
 Showing the most relevant articles for your search:NYSE:NVTA

Your Recent History

USOTC
ECSL
Ecare Solutions (PK)
USOTC
IBGR
Nexus Energy Services (PK)
USOTC
WNFT
Worldwide NFT (PK)
USOTC
MGON
Megola (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
DPLS
DarkPulse (PK)
USOTC
SFLM
SFLMaven (PK)
USOTC
VXIT
Virexit Technologies (PK)
NASDAQ
NKLA
Nikola
USOTC
ENZC
Enzolytics (PK)
NASDAQ
RVNC
Revance Therapeutics
USOTC
MVNT
Movement Industries (PK)
NASDAQ
AMRN
Amarin
NASDAQ
LWLG
Lightwave Logic
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved